Seeking Alpha
19 Nov 2026, 13:47 UTC · 5h ago
Coupang Q3: Core Recovery Intact, Regulatory Noise Pushing Out The Re-Rating
Impact · against what's priced in
The Q3 results are largely a confirmation of the current depressed valuation, as the market had already priced in margin contractions and regulatory headwinds. While revenue beats and Taiwan growth are positive, they align with the bull case the market is currently declining to pay for, providing a directional signal rather than an immediate catalyst.
- CPNG+0.15
Challenges what's priced in
- The price assumes
A return to pre-incident margin levels by mid-2027
Management explicitly identifying Q3 as the 'Product Commerce margin low' provides a concrete timeline for the recovery that the market is currently declining to price in.
What CPNG's price assumes · Sep 14




